Compound Guide
BPC-157: A Complete Research Guide
Editorial Standards
Avera Refined Wellness holds its research journal content to a standard requiring specific research claims to reference published, peer-reviewed sources — not general assertions. We are in the process of auditing and updating existing journal content to consistently meet this standard.
An in-depth look at Body Protection Compound 157 — its mechanisms, reconstitution protocol, and current state of research.
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic peptide consisting of 15 amino acids. It is derived from a protein found in human gastric juice and has become one of the most studied peptides in regenerative research.
Mechanisms of Action
BPC-157's documented mechanisms are supported by the following peer-reviewed sources:
- Angiogenesis promotion — Brcic L, et al. (PMID: 20388964) demonstrated a modulatory effect of BPC-157 on angiogenesis in muscle and tendon healing, stimulating new blood vessel formation.
- Nitric oxide pathway modulation — Yuan C, et al. (Int J Mol Sci. 2026;27(6), PMID: 41898733) provides the most comprehensive current mechanistic synthesis, confirming BPC-157's vascular and tissue healing effects operate through nitric oxide signaling pathways.
- Growth hormone receptor interaction — Chang CH, et al. (J Appl Physiol. 2011, PMID: 21030672) showed BPC-157 accelerated tendon explant outgrowth, increased fibroblast survival under oxidative stress, increased migration via FAK-paxillin phosphorylation, and produced 2.29-fold upregulation of growth hormone receptor expression in tendon fibroblasts.
- Gut-brain axis signaling — Yuan C, et al. (Int J Mol Sci. 2026;27(6), PMID: 41898733) review BPC-157's activity along the gut-brain axis and vagus nerve signaling as part of its broad mechanistic profile.
Reconstitution Protocol
For a 5mg vial with 2mL bacteriostatic water added:
- Concentration: 2.5 mg/mL (2,500 mcg/mL)
Storage
Store lyophilized (dry) peptide at -20°C for long-term storage. Once reconstituted, keep at 2–8°C and use within 30 days.
Current Research Status
A 2026 review by Yuan C, et al. (Int J Mol Sci. 2026;27(6), PMID: 41898733) confirms favorable preclinical safety data across muscle, tendon, ligament, and bone models while noting that large controlled human trials have not been completed. All research use must adhere to institutional review protocols.
All information is provided for research and educational purposes only.
Research Disclaimer: All content published in the Avera Research Journal is provided for informational and scientific discussion purposes only. It does not constitute medical advice, treatment guidance, or a recommendation for human use of any compound. All Avera products are supplied exclusively for in-vitro laboratory research by qualified professionals. Not FDA-evaluated. Not for human consumption.
This article is for informational and research purposes only. All compounds referenced are sold strictly for in-vitro laboratory research use and are not intended for human consumption, veterinary use, or clinical/diagnostic procedures. These statements have not been evaluated by the FDA. Avera Refined Wellness is a subsidiary of RDS 412 LLC.
Related Research